Dr. Jochelson on the Limitations of Mammography and Ultrasound in Screening for Breast Cancer

Video

In Partnership With:

Maxine S. Jochelson, MD, discusses the limitations of mammography and ultrasound in screening patients for breast cancer.

Maxine S. Jochelson, MD, director of radiology, Breast and Imaging Center, Memorial Sloan Kettering Cancer Center, discusses the limitations of mammography and ultrasound in screening patients for breast cancer.

Currently mammography is the standard imaging modality for women with breast cancer, says Jochelson. However, mammography has a sensitivity rate of 30% to 50% for women with dense breast tissue.

Ultrasound and mammography may be utilized for women with dense breast tissue who require additional screening, says Jochelson. However, studies have shown that even when both tools are implemented, some cancers are not identified.

As such, women with dense breast tissue or who are carriers of high-risk mutations are recommended to have yearly MRI and mammography screening. MRI appears to identify cancer earlier which may improve overall survival for patients, concludes Jochelson.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD